$AUPH It does not matter if either Dry Eye data or FDA approval news comes first because both events may surprise the wall streets and send this stock to north-pole for a huge BO. See you between $55 to $69 by the end of 2020.πŸ’ƒπŸ»πŸ•ΊπŸ»πŸ’ƒπŸ»πŸ•ΊπŸ»
  • 22